Q1 EPS Forecast for Axsome Therapeutics Increased by Analyst

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Equities researchers at Leerink Partnrs lifted their Q1 2025 EPS estimates for Axsome Therapeutics in a note issued to investors on Tuesday, February 18th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of ($1.31) for the quarter, up from their […]

Leave a Reply

Your email address will not be published.

Previous post Research Analysts Offer Predictions for IRDM Q1 Earnings
Next post Zacks Research Forecasts Lower Earnings for Allegiant Travel